Your browser doesn't support javascript.
loading
Association of preventable adverse drug events with inpatients' length of stay-A propensity-matched cohort study.
Amelung, Stefanie; Meid, Andreas D; Nafe, Michael; Thalheimer, Markus; Hoppe-Tichy, Torsten; Haefeli, Walter E; Seidling, Hanna M.
Afiliação
  • Amelung S; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Meid AD; Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany.
  • Nafe M; Pharmacy Department, Heidelberg University Hospital, Heidelberg, Germany.
  • Thalheimer M; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hoppe-Tichy T; Department of Quality Management and Medical Controlling, Heidelberg University Hospital, Heidelberg, Germany.
  • Haefeli WE; Department of Quality Management and Medical Controlling, Heidelberg University Hospital, Heidelberg, Germany.
  • Seidling HM; Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany.
Int J Clin Pract ; 71(10)2017 Oct.
Article em En | MEDLINE | ID: mdl-28873271
ABSTRACT

PURPOSE:

Using clinical administrative data (CAD) of inpatients, we aimed to identify ICD-10 codes coding for potentially preventable inhospital adverse drug events (ADE) that affect the length of hospital stay (LOS) and thus patient well-being and cost.

METHODS:

We retrospectively assessed CAD of all inpatient stays in 2012 of a German university hospital. Predefined ICD-10 codes indicating ADE (ADE codes) were further specified based on expert ratings of the ADE mechanism and ADE preventability in clinical routine to particularly identify preventable inhospital ADE. In a propensity-matched cohort design, we compared patients with one or more ADE codes to control patients with regard to differences in LOS for three situations all cases with an ADE code, cases with an inhospital ADE code, and cases with a preventable inhospital ADE code.

RESULTS:

Out of 54 032 cases analysed, in 8.3% (N=4 462) at least one ADE code was present. Nine of 128 evaluated ADE codes were rated as preventable in clinical routine, relating to 220 inpatients (4.9% of all identified inpatients with at least one ADE code and 0.4% of the entire cohort, respectively). Out of 48 072 evaluable inpatients for propensity score matching, 7 938 controls without ADE code and 4 006 cases with ADE code were selected. In all three settings, cases showed prolonged LOS vs controls (delta 1.13 d; 0.88 d and 1.88 d, respectively), significantly exceeding the maximum LOS as defined for each Diagnosis-Related Group.

CONCLUSION:

Inpatients with ADE codes referring to inhospital, potentially preventable ADE exceeded the maximum hospital stay fully reimbursed by insurance companies, indicating unnecessary long and costly inpatient stays.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Hospitalização / Tempo de Internação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Hospitalização / Tempo de Internação Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article